Legal & General Group’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
CCC
ACM
OIA
AIC
KCM
Legal & General Group's ABEO Position: Q2 2026 in Review
Legal & General Group held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 3,975 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.
Legal & General Group first reported a position in ABEO in Q2 2017 and has held it in 21 quarters since. The position peaked at $117K in Q3 2017. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.
- Legal & General Group held 3,975 shares of Abeona Therapeutics worth $24.6K as of Q2 2026.
- Legal & General Group left its Abeona Therapeutics share count unchanged in Q2 2026.
- Abeona Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3033 holding.
- Legal & General Group first reported a position in Abeona Therapeutics in Q2 2017 and has held it in 21 quarters since.
- Legal & General Group's Abeona Therapeutics position peaked at $117K in Q3 2017.
- 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.